Roswell Park Comprehensive Cancer Center
@roswellpark.bsky.social
🚨 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗶𝗻 𝗖𝗔𝗥 𝗧-𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆!
Roswell Park researchers have developed IL-36 gamma “armored” CAR T cells that reprogram neutrophils to attack solid tumors.
🔗Read the full press release here: roswellpark.org/newsroom/202...
#CARTCells #RoswellPark
Roswell Park researchers have developed IL-36 gamma “armored” CAR T cells that reprogram neutrophils to attack solid tumors.
🔗Read the full press release here: roswellpark.org/newsroom/202...
#CARTCells #RoswellPark
December 18, 2025 at 2:46 PM
🚨 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗶𝗻 𝗖𝗔𝗥 𝗧-𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆!
Roswell Park researchers have developed IL-36 gamma “armored” CAR T cells that reprogram neutrophils to attack solid tumors.
🔗Read the full press release here: roswellpark.org/newsroom/202...
#CARTCells #RoswellPark
Roswell Park researchers have developed IL-36 gamma “armored” CAR T cells that reprogram neutrophils to attack solid tumors.
🔗Read the full press release here: roswellpark.org/newsroom/202...
#CARTCells #RoswellPark
🏆 𝗢𝘂𝗿 #1 𝗕𝗹𝗼𝗴 𝗼𝗳 𝟮𝟬𝟮𝟱
From life-saving treatment to welcoming her “miracle” daughter, Megan's journey inspired more readers than any other this year. 💙
Read our top blog of 2025: 𝗧𝗵𝘆𝗿𝗼𝗶𝗱 𝗰𝗮𝗻𝗰𝗲𝗿 𝗱𝘂𝗿𝗶𝗻𝗴 𝗽𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆: 𝗠𝗲𝗴𝗮𝗻’𝘀 𝘀𝘁𝗼𝗿𝘆: bit.ly/4alUliM
From life-saving treatment to welcoming her “miracle” daughter, Megan's journey inspired more readers than any other this year. 💙
Read our top blog of 2025: 𝗧𝗵𝘆𝗿𝗼𝗶𝗱 𝗰𝗮𝗻𝗰𝗲𝗿 𝗱𝘂𝗿𝗶𝗻𝗴 𝗽𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆: 𝗠𝗲𝗴𝗮𝗻’𝘀 𝘀𝘁𝗼𝗿𝘆: bit.ly/4alUliM
December 16, 2025 at 8:46 PM
🏆 𝗢𝘂𝗿 #1 𝗕𝗹𝗼𝗴 𝗼𝗳 𝟮𝟬𝟮𝟱
From life-saving treatment to welcoming her “miracle” daughter, Megan's journey inspired more readers than any other this year. 💙
Read our top blog of 2025: 𝗧𝗵𝘆𝗿𝗼𝗶𝗱 𝗰𝗮𝗻𝗰𝗲𝗿 𝗱𝘂𝗿𝗶𝗻𝗴 𝗽𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆: 𝗠𝗲𝗴𝗮𝗻’𝘀 𝘀𝘁𝗼𝗿𝘆: bit.ly/4alUliM
From life-saving treatment to welcoming her “miracle” daughter, Megan's journey inspired more readers than any other this year. 💙
Read our top blog of 2025: 𝗧𝗵𝘆𝗿𝗼𝗶𝗱 𝗰𝗮𝗻𝗰𝗲𝗿 𝗱𝘂𝗿𝗶𝗻𝗴 𝗽𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆: 𝗠𝗲𝗴𝗮𝗻’𝘀 𝘀𝘁𝗼𝗿𝘆: bit.ly/4alUliM
Our cheer level just went way up! Huge thanks to the @nllbandits.bsky.social for lighting up Roswell Park with gifts, smiles, and all the energy they bring to the box. 🧡🏒✨
December 11, 2025 at 10:16 PM
Our cheer level just went way up! Huge thanks to the @nllbandits.bsky.social for lighting up Roswell Park with gifts, smiles, and all the energy they bring to the box. 🧡🏒✨
Congratulations to Roswell Park’s Dr. Alex Niu for winning the Chinese American Hematologist and Oncologist Network’s Young Investigator award at #ASH25 for his evaluation of outcomes and toxicities of loncastuximab tesirine (Lonca) in lymphoma 🎉
December 9, 2025 at 2:30 AM
Congratulations to Roswell Park’s Dr. Alex Niu for winning the Chinese American Hematologist and Oncologist Network’s Young Investigator award at #ASH25 for his evaluation of outcomes and toxicities of loncastuximab tesirine (Lonca) in lymphoma 🎉
Coming up at 6:00 p.m. EST on Monday, Dec. 8 at #ASH25, Dr. Elizabeth Bouchard and Dr. Kara Kelly present findings on advancing strategies to improve chemotherapy adherence in young children with ALL (Abstract 4618, West Halls B3–B4).
December 8, 2025 at 9:35 PM
Coming up at 6:00 p.m. EST on Monday, Dec. 8 at #ASH25, Dr. Elizabeth Bouchard and Dr. Kara Kelly present findings on advancing strategies to improve chemotherapy adherence in young children with ALL (Abstract 4618, West Halls B3–B4).
Coming up at 6:00 p.m. EST on Monday, Dec. 8 at #ASH25, Allan Pavy, PhD, presents new data from the Davila Lab at Roswell Park on IL-2 mutein–mediated improvement of CAR T-cell function in relapsed/refractory diffuse B-cell lymphoma (Abstract 7239, West Halls B3-B4).
December 8, 2025 at 7:43 PM
Coming up at 6:00 p.m. EST on Monday, Dec. 8 at #ASH25, Allan Pavy, PhD, presents new data from the Davila Lab at Roswell Park on IL-2 mutein–mediated improvement of CAR T-cell function in relapsed/refractory diffuse B-cell lymphoma (Abstract 7239, West Halls B3-B4).
Starting soon at #ASH25, Dr. Eunice Wang share findings on crenolanib and ziftomenib combinations targeting multiple mutations, which show promise for AML patients with relapse disease. (Chaplin Theater, W320).
Learn more: www.roswellpark.org/newsroom/202...
Learn more: www.roswellpark.org/newsroom/202...
December 8, 2025 at 4:37 PM
Starting soon at #ASH25, Dr. Eunice Wang share findings on crenolanib and ziftomenib combinations targeting multiple mutations, which show promise for AML patients with relapse disease. (Chaplin Theater, W320).
Learn more: www.roswellpark.org/newsroom/202...
Learn more: www.roswellpark.org/newsroom/202...
(3/3)
December 8, 2025 at 2:29 PM
(3/3)
(2/3)
December 8, 2025 at 2:29 PM
(2/3)
Exciting research emerging from Roswell Park is being shared throughout the day at #ASH25. Here's what's coming up on Monday from our experts. (1/3)
December 8, 2025 at 2:29 PM
Exciting research emerging from Roswell Park is being shared throughout the day at #ASH25. Here's what's coming up on Monday from our experts. (1/3)
🎶Let’s go Buffalo!🎶
Thank you to everyone at ASH who made it to our “tailgate” reception and enjoyed the big win (and apologies for all the SHOUT-ing).
Thank you to everyone at ASH who made it to our “tailgate” reception and enjoyed the big win (and apologies for all the SHOUT-ing).
December 8, 2025 at 12:55 AM
🎶Let’s go Buffalo!🎶
Thank you to everyone at ASH who made it to our “tailgate” reception and enjoyed the big win (and apologies for all the SHOUT-ing).
Thank you to everyone at ASH who made it to our “tailgate” reception and enjoyed the big win (and apologies for all the SHOUT-ing).
Hear from some of our experts in hematology and oncology on why conferences like #ASH25 are so important. #fight4hematology
December 7, 2025 at 8:22 PM
Hear from some of our experts in hematology and oncology on why conferences like #ASH25 are so important. #fight4hematology
Coming up at 1:15 p.m., Dr. Meredith Stone presents findings from the Davila Lab Group at Roswell Park on CAR T cell-driven induction of iNOS in tumor-associated macrophages, which promote CAR T-cell resistance in B cell lymphoma. (Oral Abstract #13711 in Tangerine Ballroom F1) #ASH25
December 7, 2025 at 5:14 PM
Coming up at 1:15 p.m., Dr. Meredith Stone presents findings from the Davila Lab Group at Roswell Park on CAR T cell-driven induction of iNOS in tumor-associated macrophages, which promote CAR T-cell resistance in B cell lymphoma. (Oral Abstract #13711 in Tangerine Ballroom F1) #ASH25
At #ASH25? We invite you to meet with some of the experts in transplant, cellular therapy, and hematology who are helping Roswell Park become a leader in cellular therapy innovation. Come to booth #2179 to learn about our clinical trials, new approaches, and our new GMP/Cell Manufacturing Facility.
December 7, 2025 at 2:14 PM
At #ASH25? We invite you to meet with some of the experts in transplant, cellular therapy, and hematology who are helping Roswell Park become a leader in cellular therapy innovation. Come to booth #2179 to learn about our clinical trials, new approaches, and our new GMP/Cell Manufacturing Facility.
(3/3)
December 7, 2025 at 12:59 PM
(3/3)
(2/3)
December 7, 2025 at 12:59 PM
(2/3)
More exciting research in cellular therapy, transplant, and hematologic oncology is being shared throughout the day on Sunday at #ASH25. From oral abstracts to poster presentations, here's everything to keep an eye on from Roswell Park! (1/3)
December 7, 2025 at 12:59 PM
More exciting research in cellular therapy, transplant, and hematologic oncology is being shared throughout the day on Sunday at #ASH25. From oral abstracts to poster presentations, here's everything to keep an eye on from Roswell Park! (1/3)
We look forward to sharing more on the advancements in cellular therapies and hematological oncology coming out of Buffalo!
December 7, 2025 at 12:24 AM
We look forward to sharing more on the advancements in cellular therapies and hematological oncology coming out of Buffalo!
🎥 Behind the scenes with Dr. Ehsan Malek and @vjhemonc.bsky.social — diving into how AI tools can be effectively integrated into CAR T-cell therapies for cancer care. 💡🧬
December 6, 2025 at 10:45 PM
🎥 Behind the scenes with Dr. Ehsan Malek and @vjhemonc.bsky.social — diving into how AI tools can be effectively integrated into CAR T-cell therapies for cancer care. 💡🧬
Exciting career opportunities are happening at Roswell Park! Stop by booth #2179 to see how you could be a part of the hem-onc and cell therapy innovations happening in Buffalo! #ASH25
December 6, 2025 at 7:13 PM
Exciting career opportunities are happening at Roswell Park! Stop by booth #2179 to see how you could be a part of the hem-onc and cell therapy innovations happening in Buffalo! #ASH25
We're here at #ASH25! Here's a list of sessions coming up today from Roswell Park's experts. If you can't make any of these sessions live, be sure to stop by our booth (#2179) to learn more about the cellular therapy and Hem-Onc. innovations going on at Roswell Park.
December 6, 2025 at 3:44 PM
We're here at #ASH25! Here's a list of sessions coming up today from Roswell Park's experts. If you can't make any of these sessions live, be sure to stop by our booth (#2179) to learn more about the cellular therapy and Hem-Onc. innovations going on at Roswell Park.
Learn more and continue the conversations on cell therapy advancements by stopping by our booth (#2179). Many of Roswell Park’s staff will be there throughout the conference!
December 6, 2025 at 2:45 PM
Learn more and continue the conversations on cell therapy advancements by stopping by our booth (#2179). Many of Roswell Park’s staff will be there throughout the conference!